AI Engines For more Details: Perplexity Kagi Labs You
Venous Insufficiency: Beta-escin is commonly used in the treatment of chronic venous insufficiency (CVI), a condition characterized by impaired blood flow in the veins, usually in the legs. It helps strengthen and tone the walls of the veins, reducing inflammation and leakage of fluids into the surrounding tissues. Beta-escin may alleviate symptoms of CVI, such as leg swelling, pain, heaviness, and cramping, and improve venous circulation.
Varicose Veins: Beta-escin is also used in the management of varicose veins, which are enlarged, twisted veins that typically occur in the legs. It helps reduce venous congestion and inflammation, improve venous tone and elasticity, and decrease capillary permeability. Beta-escin may alleviate symptoms associated with varicose veins, such as pain, swelling, itching, and skin discoloration.
Hemorrhoids: Beta-escin is sometimes used topically or orally to relieve symptoms of hemorrhoids, which are swollen and inflamed veins in the rectum and anus. It helps reduce swelling, inflammation, and discomfort associated with hemorrhoids and may promote healing of anal fissures and ulcers. Beta-escin may be formulated into creams, ointments, suppositories, or oral preparations for the treatment of hemorrhoids.
Edema: Beta-escin has mild diuretic properties and may help reduce edema (fluid retention) by increasing urine production and promoting fluid excretion from the body. It may be used as an adjunctive therapy for managing edema associated with conditions such as heart failure, kidney disease, liver cirrhosis, and lymphedema. Beta-escin may help alleviate swelling and improve symptoms of fluid overload.
Anti-inflammatory Effects: Beta-escin exhibits anti-inflammatory properties and may help reduce inflammation in various tissues and organs. It inhibits the release of pro-inflammatory mediators and cytokines, decreases vascular permeability, and suppresses leukocyte migration and activation. Beta-escin may be beneficial in inflammatory conditions such as arthritis, tendonitis, bursitis, and dermatitis.
Antioxidant Activity: Beta-escin has antioxidant properties and may help neutralize free radicals and reactive oxygen species (ROS) that contribute to oxidative stress and tissue damage. It scavenges free radicals, enhances antioxidant defenses, and protects cells and tissues from oxidative damage. Beta-escin may have potential applications in preventing or mitigating oxidative stress-related diseases and aging-related disorders.
Wound Healing: Beta-escin may promote wound healing by stimulating tissue repair and regeneration processes. It helps reduce inflammation, edema, and pain at the wound site, improves blood flow and oxygenation, and enhances the formation of granulation tissue and collagen deposition. Beta-escin may be used in the management of chronic wounds, such as venous ulcers, pressure ulcers, and diabetic foot ulcers.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium breve | Reduces |
species | Bifidobacterium longum | Reduces |
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Bilophila | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Shigella | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Parolsenella | genus | Decreases |
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Lacticaseibacillus | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
1 | 0 | Segatella copri | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
1 | 0 | Parabacteroides merdae | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
0 | 1 | Shigella flexneri | species | Decreases |
0 | 1 | Escherichia albertii | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Roseburia hominis | species | Decreases |
0 | 1 | Escherichia fergusonii | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
0 | 1 | Segatella bryantii | species | Decreases |
0 | 1 | Shigella boydii | species | Decreases |
0 | 1 | Leyella stercorea | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
0 | 1 | Shigella sonnei | species | Decreases |
0 | 1 | Parolsenella catena | species | Decreases |
0 | 1 | Escherichia marmotae | species | Decreases |
0 | 1 | Parolsenella massiliensis | species | Decreases |
0 | 1 | Prevotella intermedia | species | Decreases |
0 | 1 | Escherichia sp. E4742 | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
0 | 1 | Bifidobacterium angulatum | species | Decreases |
0 | 1 | Collinsella stercoris | species | Decreases |
0 | 1 | Leyella lascolaii | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Paraprevotella clara | species | Decreases |
0 | 1 | Prevotella bivia | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Bifidobacterium breve | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Prevotella dentalis | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
1 | 0 | Streptococcus salivarius | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
1 | 0 | Roseburia intestinalis | species | Decreases |
1 | 0 | Lacticaseibacillus paracasei | species | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. paracasei | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. tolerans | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.3 | 0.3 | |
Acne | 0.2 | -0.2 | |
ADHD | 1.7 | 0.1 | 16 |
Age-Related Macular Degeneration and Glaucoma | 0.1 | 0.2 | -1 |
Allergic Rhinitis (Hay Fever) | 1.1 | 1.6 | -0.45 |
Allergies | 4 | 2 | 1 |
Allergy to milk products | 1.3 | 0.9 | 0.44 |
Alopecia (Hair Loss) | 0.4 | 0.4 | |
Alzheimer's disease | 2.7 | 2.9 | -0.07 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1 | 0.8 | 0.25 |
Ankylosing spondylitis | 2.6 | 0.4 | 5.5 |
Anorexia Nervosa | 0.7 | 0.9 | -0.29 |
Antiphospholipid syndrome (APS) | 0.7 | 0.3 | 1.33 |
Asthma | 2.1 | 1 | 1.1 |
Atherosclerosis | 1.8 | 0.2 | 8 |
Atrial fibrillation | 1.3 | 1.9 | -0.46 |
Autism | 3.5 | 4.2 | -0.2 |
Autoimmune Disease | 0.7 | 0.3 | 1.33 |
Barrett esophagus cancer | 0.1 | 0 | 0 |
benign prostatic hyperplasia | 0.5 | 0.1 | 4 |
Biofilm | 0.9 | 0.9 | |
Bipolar Disorder | 1.3 | 0.4 | 2.25 |
Brain Trauma | 0.5 | 0.6 | -0.2 |
Breast Cancer | 0.6 | 0.6 | |
Cancer (General) | 0.1 | 1.1 | -10 |
Carcinoma | 1.7 | 1 | 0.7 |
Celiac Disease | 1.5 | 1.5 | 0 |
Cerebral Palsy | 0.5 | 0.5 | 0 |
Chronic Fatigue Syndrome | 2.3 | 2.1 | 0.1 |
Chronic Kidney Disease | 2.1 | 0.7 | 2 |
Chronic Lyme | 0.6 | 0.2 | 2 |
Chronic Obstructive Pulmonary Disease (COPD) | 0.9 | 0.3 | 2 |
Chronic Urticaria (Hives) | 1.1 | 0.9 | 0.22 |
Coagulation / Micro clot triggering bacteria | 1.3 | 0.5 | 1.6 |
Cognitive Function | 1 | 0.3 | 2.33 |
Colorectal Cancer | 2.9 | 1.3 | 1.23 |
Constipation | 0.8 | 0.2 | 3 |
Coronary artery disease | 1.7 | 0.8 | 1.13 |
COVID-19 | 4.3 | 3.7 | 0.16 |
Crohn's Disease | 3.7 | 1.5 | 1.47 |
Cushing's Syndrome (hypercortisolism) | 0.1 | -0.1 | |
cystic fibrosis | 0.9 | 0.9 | 0 |
d-lactic acidosis (one form of brain fog) | 0.6 | 0.6 | |
deep vein thrombosis | 1.5 | 0.5 | 2 |
Denture Wearers Oral Shifts | 0.3 | 0.3 | |
Depression | 4 | 3.7 | 0.08 |
Dermatomyositis | 0 | 0.2 | 0 |
Eczema | 0.8 | 1 | -0.25 |
Endometriosis | 1.9 | 1.1 | 0.73 |
Eosinophilic Esophagitis | 0.1 | -0.1 | |
Epilepsy | 2.2 | 0.9 | 1.44 |
erectile dysfunction | 0.6 | 0.2 | 2 |
Fibromyalgia | 0.9 | 1.2 | -0.33 |
Functional constipation / chronic idiopathic constipation | 2.8 | 2.2 | 0.27 |
gallstone disease (gsd) | 1.9 | 0.3 | 5.33 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.4 | 0.3 | 0.33 |
Generalized anxiety disorder | 1.6 | 0.7 | 1.29 |
giant cell arteritis | 0 | 0 | |
Glioblastoma | 0 | 0 | |
Gout | 1 | 0.3 | 2.33 |
Graves' disease | 1 | 1.1 | -0.1 |
Gulf War Syndrome | 0.2 | 0.5 | -1.5 |
Halitosis | 0.3 | 0 | 0 |
Hashimoto's thyroiditis | 1.1 | 0.6 | 0.83 |
Heart Failure | 2.4 | 0.6 | 3 |
hemorrhagic stroke | 0.2 | 0.2 | |
Hidradenitis Suppurativa | 0.5 | 0.1 | 4 |
High Histamine/low DAO | 0.7 | 0.4 | 0.75 |
hypercholesterolemia (High Cholesterol) | 0.6 | 0.6 | |
hyperglycemia | 1.4 | 0.6 | 1.33 |
Hyperlipidemia (High Blood Fats) | 0.8 | 0.3 | 1.67 |
hypersomnia | 0.7 | -0.7 | |
hypertension (High Blood Pressure | 1.9 | 2.4 | -0.26 |
Hypothyroidism | 0.1 | 0.4 | -3 |
Hypoxia | 0.5 | 0.5 | |
IgA nephropathy (IgAN) | 0.5 | 1.8 | -2.6 |
Inflammatory Bowel Disease | 4.1 | 5.1 | -0.24 |
Insomnia | 0.5 | 0.7 | -0.4 |
Intelligence | 0.9 | 0.6 | 0.5 |
Intracranial aneurysms | 0.7 | 0.3 | 1.33 |
Irritable Bowel Syndrome | 3.1 | 1.7 | 0.82 |
ischemic stroke | 1.8 | 0.7 | 1.57 |
Liver Cirrhosis | 3.2 | 1.7 | 0.88 |
Long COVID | 1.7 | 3.4 | -1 |
Low bone mineral density | 0.1 | -0.1 | |
Lung Cancer | 1 | 0.3 | 2.33 |
Lymphoma | 0.5 | 0.5 | |
Mast Cell Issues / mastitis | 0.6 | 0.4 | 0.5 |
ME/CFS with IBS | 0.1 | 0.8 | -7 |
ME/CFS without IBS | 0.2 | 0.4 | -1 |
membranous nephropathy | 0 | 0 | |
Menopause | 1 | 0.1 | 9 |
Metabolic Syndrome | 4.4 | 2.9 | 0.52 |
Mood Disorders | 3.6 | 3.2 | 0.13 |
multiple chemical sensitivity [MCS] | 0.2 | 0.1 | 1 |
Multiple Sclerosis | 2.5 | 1.9 | 0.32 |
Multiple system atrophy (MSA) | 0.3 | 0.5 | -0.67 |
myasthenia gravis | 0.6 | 0.1 | 5 |
neuropathic pain | 0.7 | -0.7 | |
Neuropathy (all types) | 0.2 | 0.5 | -1.5 |
neuropsychiatric disorders (PANDAS, PANS) | 0.7 | 0.7 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 2.9 | 1.7 | 0.71 |
NonCeliac Gluten Sensitivity | 0.7 | 0.3 | 1.33 |
Obesity | 4.6 | 2.4 | 0.92 |
obsessive-compulsive disorder | 3.4 | 1.3 | 1.62 |
Osteoarthritis | 0.8 | 0.5 | 0.6 |
Osteoporosis | 1 | 0.4 | 1.5 |
pancreatic cancer | 0 | 0 | 0 |
Parkinson's Disease | 4.6 | 2.9 | 0.59 |
Polycystic ovary syndrome | 2.8 | 1.5 | 0.87 |
Postural orthostatic tachycardia syndrome | 0 | 0.2 | 0 |
Premenstrual dysphoric disorder | 0.6 | 0.2 | 2 |
primary biliary cholangitis | 0.1 | 0.4 | -3 |
Primary sclerosing cholangitis | 0.6 | 1 | -0.67 |
Psoriasis | 2.1 | 1.1 | 0.91 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 4 | 1.2 | 2.33 |
Rosacea | 0.4 | 0.1 | 3 |
Schizophrenia | 2.6 | 1 | 1.6 |
scoliosis | 0.7 | 0.5 | 0.4 |
Sjögren syndrome | 1.8 | 1.1 | 0.64 |
Sleep Apnea | 0.8 | 0.4 | 1 |
Slow gastric motility / Gastroparesis | 1 | 0.2 | 4 |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.9 | 0.3 | 2 |
Stress / posttraumatic stress disorder | 1.4 | 0.9 | 0.56 |
Systemic Lupus Erythematosus | 1.9 | 1.2 | 0.58 |
Tic Disorder | 0.2 | 1.4 | -6 |
Tourette syndrome | 0 | 0.1 | 0 |
Type 1 Diabetes | 2.1 | 1.5 | 0.4 |
Type 2 Diabetes | 3.8 | 2.6 | 0.46 |
Ulcerative colitis | 2.2 | 3.3 | -0.5 |
Unhealthy Ageing | 1.7 | 0.5 | 2.4 |
Vitiligo | 1 | 0.5 | 1 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]